SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020836
Filing Date
2023-05-11
Accepted
2023-05-11 07:19:55
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pyxs-20230331.htm   iXBRL 10-Q 2324159
2 EX-31.1 pyxs-ex31_1.htm EX-31.1 20218
3 EX-31.2 pyxs-ex31_2.htm EX-31.2 20225
4 EX-32.1 pyxs-ex32_1.htm EX-32.1 12402
5 EX-32.2 pyxs-ex32_2.htm EX-32.2 11709
6 GRAPHIC img31495689_0.jpg GRAPHIC 66689
  Complete submission text file 0000950170-23-020836.txt   7715446

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230331.xsd EX-101.SCH 46550
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230331_pre.xml EX-101.PRE 302760
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230331_lab.xml EX-101.LAB 399274
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pyxs-20230331_cal.xml EX-101.CAL 31879
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pyxs-20230331_def.xml EX-101.DEF 181799
63 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230331_htm.xml XML 1191058
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 23908809
SIC: 2834 Pharmaceutical Preparations